GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » EV-to-EBITDA

Precision BioSciences (FRA:PBS0) EV-to-EBITDA : 0.85 (As of May. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Precision BioSciences's enterprise value is €-15.04 Mil. Precision BioSciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €-17.78 Mil. Therefore, Precision BioSciences's EV-to-EBITDA for today is 0.85.

The historical rank and industry rank for Precision BioSciences's EV-to-EBITDA or its related term are showing as below:

FRA:PBS0' s EV-to-EBITDA Range Over the Past 10 Years
Min: -25.42   Med: -2.24   Max: 3.09
Current: 0.85

During the past 7 years, the highest EV-to-EBITDA of Precision BioSciences was 3.09. The lowest was -25.42. And the median was -2.24.

FRA:PBS0's EV-to-EBITDA is ranked better than
68.86% of 456 companies
in the Biotechnology industry
Industry Median: 10.52 vs FRA:PBS0: 0.85

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Precision BioSciences's stock price is €11.60. Precision BioSciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-6.804. Therefore, Precision BioSciences's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Precision BioSciences EV-to-EBITDA Historical Data

The historical data trend for Precision BioSciences's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences EV-to-EBITDA Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -6.06 -3.63 -15.59 0.52 1.24

Precision BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.99 1.27 1.24 0.67

Competitive Comparison of Precision BioSciences's EV-to-EBITDA

For the Biotechnology subindustry, Precision BioSciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precision BioSciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's EV-to-EBITDA falls into.



Precision BioSciences EV-to-EBITDA Calculation

Precision BioSciences's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-15.040/-17.783
=0.85

Precision BioSciences's current Enterprise Value is €-15.04 Mil.
Precision BioSciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-17.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Precision BioSciences  (FRA:PBS0) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Precision BioSciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.60/-6.804
=At Loss

Precision BioSciences's share price for today is €11.60.
Precision BioSciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.804.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Precision BioSciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Precision BioSciences (FRA:PBS0) Business Description

Traded in Other Exchanges
Address
302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines